Table 6.
The top five lncRNA candidates predicted for cervical cancer, glioma, and non-small-cell lung cancer.
| Disease | lncRNA | Evidence |
|---|---|---|
| Cervical cancer | MEG3 | LncRNADisease (Zhang J. et al., 2016) |
| Cervical cancer | PVT1 | LncRNADisease (Yang et al., 2016) |
| Cervical cancer | CDKN2B-AS1 | LncRNADisease (Zhang D. et al., 2016) |
| Cervical cancer | HOTAIR | LncRNADisease (Huang et al., 2014) |
| Cervical cancer | GAS5 | LncRNADisease (Cao et al., 2014) |
| Glioma | H19 | LncRNADisease (Shi et al., 2014) |
| Glioma | MALAT1 | LncRNADisease (Ma et al., 2015) |
| Glioma | PVT1 | (Zou et al., 2017) |
| Glioma | HOTAIR | LncRNADisease (Ke et al., 2015) |
| Glioma | GAS5 | LncRNADisease (Zhao X. et al., 2015) |
| Non-small-cell lung cancer | H19 | LncRNADisease (Zhang E. et al., 2016) |
| Non-small-cell lung cancer | MEG3 | LncRNADisease (Lu et al., 2013) |
| Non-small-cell lung cancer | HOTAIR | LncRNADisease (Liu X. H. et al., 2013) |
| Non-small-cell lung cancer | PVT1 | LncRNADisease (Yang et al., 2014) |
| Non-small-cell lung cancer | CDKN2B-AS1 | LncRNADisease (Nie et al., 2015) |